ReviewWorld journal of gastroenterology2026
Deep learning techniques for using computed tomography imaging for hepatocellular carcinoma diagnosis, treatment and prognosis.
Review in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, significantly threatens to global health. Despite considerable advances in diagnostic and therapeutic approaches in recent years, the prognosis for patients with HCC remains unsatisfactory. The emergence of artificial intelligence (AI), particularly deep learning technologies, offers new hope for improving the diagnosis and treatment of HCC. Researchers have extensively explored ways to integrate deep learning models into the clinical management of HCC patients, which provides a valuable foundation for developing more personalized treatment strategies. Compared with other detection methods, computed tomography (CT) has attracted significant research interest because of its comprehensive advantages, including wide availability and high resolution, making it well suited for AI-powered analysis. This review systematically integrates deep learning technologies for HCC based on CT imaging, while focusing primarily on tumor diagnosis, segmentation, treatment response prediction, and patient prognosis prediction. Moreover, we review popular deep learning networks in various fields and describe the advantages of these prevalent deep learning models for different applications. Furthermore, we discuss the outstanding challenges in applying deep learning to extract information from CT images for the diagnosis and treatment of HCC patients. These insights could provide guidance for subsequent studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.